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ABSTRACT The oligopeptide transporter Opp is a ﬁve-component ABC uptake system. The extracytoplasmic lipid-anchored
substrate-binding protein (or receptor) OppA delivers peptides to an integral membrane complex OppBCDF (or translocator),
where, on ATP binding and hydrolysis, translocation across the membrane takes place. OppA and OppBCDF were labeled with
ﬂuorescent probes, reconstituted into giant unilamellar vesicles, and the receptor-translocator interactions were investigated by
ﬂuorescence correlation spectroscopy. Lateral mobility of OppA was reduced on incorporation of OppBCDF into giant unilamellar
vesicles, and decreased even further on the addition of peptide. Fluorescence cross-correlation measurements revealed that
OppBCDF distinguished liganded from unliganded OppA, binding only the former. Addition of ATP or its nonhydrolyzable analog
AMP-PNP resulted in release of OppA from OppBCDF. In vanadate-trapped ‘‘transition state’’ conditions, OppA also was not
bound by OppBCDF. A model is presented in which ATP-binding to OppDF results in donation of peptide to OppBC and
simultaneous release of OppA. ATP-hydrolysis would complete the peptide translocation and reset the transporter for another
catalytic cycle. Implications in terms of a general transport mechanism for ABC importers and exporters are discussed.
INTRODUCTION
ABC transporters compose one of the largest protein fami-
lies, and their function and dysfunction are in a number of
cases linked to human diseases (1,2). ABC transporters cat-
alyze the unidirectional transport of a wide variety of sub-
strates over cellular and organellar membranes and are
widely distributed throughout all forms of life. Two hydro-
phobic TMDs create the translocation pathway, and two
peripherally associated NBDs fuel the transport reaction by
binding and hydrolyzing ATP. Directionality of the translo-
cation process can be deduced from the presence or absence
of a ﬁfth component, the extracytoplasmic SBP (also termed
receptor). ABC efﬂux systems lack this constituent, whereas
in bacterial ABC importers the SBP is essential for function.
A vast amount of experimental data is available for dif-
ferent ABC efﬂux systems, and although mechanistic details
may differ in individual cases, a consensus model on how this
type of transporters work is emerging (3,4). Substrate is
bound at a high-afﬁnity cytoplasmic facing binding site, lo-
cated within the TMDs. ATP-binding induces NBD dimer-
ization and reorientation of the loaded substrate-binding site
from a high afﬁnity inside- to a low afﬁnity outside-facing
conformation. After substrate release, ATP-hydrolysis resets
the transporter by opening the NBDs and reorienting the
empty binding site.
Data on SBP-dependent ABC importers are limited to one
or two systems as an experimentally well supported transport
mechanism is currently available only for the maltose per-
mease MalEFGK2 from Escherichia coli (5–7) and, to a
lesser extent, the histidine permease HisJQMP2 from Sal-
monella typhimurium (8,9). In a series of elegant experi-
ments, Davidson and colleagues showed that liganded SBP
MalE, while bound to the TMDs (MalF and G), opens on
ATP-binding to the NDBs (two copies of MalK per func-
tional complex). In the vanadate-trapped transition state for
ATP-hydrolysis, MalE, in its open conformation, is bound
tightly to MalFGK2, whereas the afﬁnity for maltose is re-
duced. Under posthydrolysis conditions MalE dissociates
from MalFGK2, thereby resetting the transporter for the next
catalytic cycle. These data contrast those of the vitamin B12
transporter Btu, where SBP BtuF binds tightly to BtuCD in
the absence and presence of MgATP, and might not disso-
ciate from the transporter during the catalytic cycle (10). In
fact, the recent crystal structure of the BtuCD-F complex
reveals BtuF in (at least partial) open conformation (11),
suggesting a posttranslocation state of BtuCD with tightly
bound, unliganded SBP.
The oligopeptide ABC transporter OppABCDF from
Lactococcus lactis is composed of an extracytoplasmic lipid-
anchored SBP, OppA, two TMDs, OppB and C, and two
doi: 10.1529/biophysj.107.120964
Submitted September 2, 2007, and accepted for publication December 21,
2007.
Address reprint requests to Bert Poolman, Dept. of Biochemistry, Groningen
Biomolecular Sciences and Biotechnology Institute and Zernike Insti-
tute for Advanced Materials, Nijenborgh 4, 9747 AG Groningen, The
Netherlands. Tel. 31-50-3634190; Fax. 31-50-3634165; E-Mail: b.poolman@
rug.nl.
Mark K. Doeven’s present address is Dept. of Pediatrics, Center for Liver,
Digestive and Metabolic Diseases, University Medical Center Groningen,
Hanzeplein 1, PO Box 30.001, 9700 RB Groningen, The Netherlands.
Abbreviations used: ABC, ATP-binding cassette; DDM. n-dodecyl-b-D-
maltoside; FCS, ﬂuorescence correlation spectroscopy; FCCS, ﬂuorescence
cross-correlation spectroscopy; GUV, giant unilamellar vesicle; LUV, large
unilamellar vesicle; NBD, nucleotide-binding domain; SBP, substrate-binding
protein; TMD, transmembrane domain.
Editor: Thomas Schmidt.
 2008 by the Biophysical Society
0006-3495/08/05/3956/10 $2.00
3956 Biophysical Journal Volume 94 May 2008 3956–3965
NBDs, OppD and F, bound to the cytosolic face of the TMDs
(12). In vitro transport assays with puriﬁed proteins recon-
stituted in LUVs suggested that OppBCDF speciﬁcally rec-
ognizes liganded OppA (13). This ﬁnding contrasted with
observations for the maltose and histidine transporters, where
unliganded SBP seemed to have access to the TMDs as well,
thereby inhibiting transport activity (14–16).
We now used puriﬁed and ﬂuorescent-labeled OppA and
OppBCDF, incorporated into giant unilamellar vesicles, to
probe the interactions between the receptor and translocator
of the oligopeptide ABC transporter, using ﬂuorescence
auto- and cross-correlation spectroscopy (17). Based on the
results, a model for oligopeptide transport is presented which
shows similarities but also differences compared with the
mechanism proposed for the maltose permease. The possible
origins for the observed differences are discussed, thereby
increasing our knowledge on the translocation mechanism of
SBP-dependent ABC transporters.
EXPERIMENTAL PROCEDURES
Bacterial strain and growth conditions
C-terminal His6-tagged OppA, OppA I602C, and OppBCDF (His6-tag on
C-terminus of OppC) were produced in L. lactis AMP2/pAMP31, NZ9000/
pNZOppA (I602C) andNZ9000/pAMP42, respectively, as described (13,18,
19). C-terminal His6-tagged LacS C320A/A635C was produced by E. coli
HB101, using the pSKE8his expression vector as described (19). Plasmid
pAMP42 (OppC I296C) was an intermediate product in the construction of
pNZOppA (I602C) and was used for production of OppBC(I296C)DF by
L. lactisNZ9000. Cells were grown in 5% (w/v) whey-permeate, 0.5% (w/v)
yeast extract, 0.5% (w/v) glucose, and 65 mM KPi, pH 7.0, supplemented
with 5 mg/mL chloramphenicol in volumes of 10 L in a bioreactor with pH
control (ADI 1065 fermentor; Applikon Dependable Instruments B. V.,
Schiedam, The Netherlands). The pHwas kept constant at pH 6.5 by titrating
with 2 M KOH. Trancription from the nisin A promoter (plasmid constructs
in strain NZ9000) was induced at an OD660 of 2 by adding 1:1000 (v/v) of the
culture supernatant of L. lactis NZ9700. Cells were harvested by centrifu-
gation, washed with 100 mM KPi, pH 7.0, resuspended in 100 mM KPi, pH
7.0, plus 20% (v/v) glycerol, and stored at 80C.
Protein puriﬁcation and ﬂuorescent labeling
OppA and OppBCDF were puriﬁed as described (13,18). OppA I605C and
LacS C320A/A635C were puriﬁed and labeled with Alexa Fluor 488 C5
maleimide (Invitrogen) as described (19). Labeling of OppA I605C and LacS
C320A/A635Cwith Alexa Fluor 633 C5maleimide (Invitrogen) was done in
exactly the same way as previously described for Alexa Fluor 488 C5 mal-
eimide (19). OppBC(I296C)DF was puriﬁed and labeled with either Alexa
Fluor 488 or Alexa Fluor 633 as follows. Membrane vesicles were prepared
by rupturing the cells with a high-pressure homogenizer (Kindler Maschinen
AG, Zu¨rich, Switzerland) in the presence of 20% (v/v) glycerol. OppB-
C(I296C)DF containing membranes were resuspended to 5 mg/mL of total
membrane protein in 50 mM KPi, pH 8.0, 200 mM KCl, and 20% (v/v)
glycerol (buffer A), and solubilized with 0.5% (w/v) DDM. After 12 min of
centrifugation at 280,000 3 g and 4C, the supernatant was diluted ﬁve
times with buffer A and incubated with nickel-nitrilotriacetic acid resin (0.05
mL/mg of total membrane protein) for 1.5 h at 4C while shaking gently.
Subsequently, the resin was poured into a column and washed with 20 col-
umn volumes of buffer A, supplemented with 0.05% (w/v) DDM and 10mM
imidazole. Labeling was done by incubating the puriﬁed protein while bound
to the column for 2 h up to overnight at 4C with an;30 times molar excess
of probe dissolved in ﬁve column volumes buffer A plus 0.05% (w/v) DDM.
The column was washed with 20 column volumes buffer A plus 0.05% (w/v)
DDM to remove free label, and the labeled OppBC(I296C)DF complex was
eluted in the same buffer, pH 7.0, supplemented with 100 mM histidine. The
degree of labeling was estimated bymeasuring the absorbance of Alexa Fluor
488 and 633 (extinction coefﬁcients are 71,000 M1cm1 at 495 nm and
100,000 M1cm1 at 633 nm, respectively) and determination of protein
concentration and was found to be 80–100% for each protein preparation.
The protein concentrations were estimated from A280 measurements (the
extinction coefﬁcients of OppA, OppBCDF, and LacS are 1.605, 0.990, and
0.926 (mg/mL)1cm1, respectively) and corrected for absorption at 280 nm
by the Alexa Fluor dyes.
Reconstitution of (ﬂuorescent-labeled) Opp
proteins in LUVs and GUVs
Triton X-100 mediated incorporation of the ﬂuorescent-labeled Opp proteins
into LUVs was done as described (for speciﬁc details see Doeven and col-
leagues (13); for generic procedure see Poolman and colleagues(20) and
Rigaud, Pitard, and Levy (21)). First, OppBC(I296C)DFwas reconstituted at
a 1:20 or 1:100 (w/w) protein/lipid ratio as speciﬁed further in the Results.
Second, OppA(I602C) was attached to (OppBC(I296C)DF containing) lip-
osomes at a 1:50 (w/w) protein/lipid ratio, which corresponds to ;3.5 nmol
OppA/m2 of membrane surface (13). Third, Opp-containing LUVs were
converted into proteo-GUVs, essentially as described (19). Brieﬂy, proteo-
LUVs in 50 mM NH4HCO3, pH 8.0, were frozen and thawed three times in
the presence of 0.1 g of sucrose/g lipids. 10 mL proteo-LUVs (5 mg/mL
lipids) were dried on an ultraviolet-ozone cleaned cover-slide under a gentle
stream of nitrogen gas, followed by an overnight incubation under vacuum
at 4C. Rehydration was done by adding 500 mL of 20 mM K-Hepes, pH
8.0. GUV formation was monitored by ﬂuorescence microscopy. Optionally,
bradykinin (a nonameric peptide with the amino acid sequence RPPGF-
SPFR) and/or nucleotides were included in the rehydration buffer. The dis-
tributions of peptide and/or nucleotide on the inside and outside of the GUVs
after vesicle formation was assessed in control experiments by including
tracer amounts (;10 nM) of Oregon Green 488-labeled RPPGFSPFC or
Alexa Fluor 647-ATP (Invitrogen) in the rehydration buffer, followed by
confocal imaging of the formed GUVs (see below). At the concentrations of
peptide and nucleotides used, i.e. 20 mM and 0.1 – 3 mM, respectively, no
signiﬁcant differences between the amounts of solutes present inside and
outside the proteo-GUVs could be detected.
Activity of ﬂuorescent-labeled Opp
Activity of the ﬂuorescent-labeled proteins was determined as described
previously by measuring peptide binding (OppA; (18)) and/or peptide
transport (OppABCDF; (13)). These measurements were performed at 30C.
Confocal imaging, FCS and FCCS measurements
FCS measurements were carried out at 18C on a dual-color laser scanning
confocal microscope. For the measurements, 10 mL proteo-LUVs (5 mg/mL
lipids), rehydrated in 500 mL of 20 mMK-Hepes, pH 8.0, w/wo peptide and/
or nucleotides (see ﬁgure legends) were used. A carefully optimized amount
of sucrose was added to the proteo-LUVs before the dehydration step (0.1 g
sucrose/g lipids; (19)). Sucrose protects the proteins by providing critical
hydrogen bonds on dehydration and suppressing the liquid crystalline-gel
phase transition in the membrane on dehydration-rehydration (and thereby
prevents the proteins from aggregating) (19). Too much sucrose, albeit not
unfavorable for the proteins, inhibited GUV formation. Local variations in
the sugar concentration and of the dried lipid layer most likely caused the
observed heterogeneities in ﬂuorescence intensity within a single sample of
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GUVs. These heterogeneities reﬂect differences in protein/lipid ratios be-
tween the GUVs; the diffusion coefﬁcients of the proteins in the different
GUVs are presented in Supplementary Material, Fig. S1. At high protein/
lipid ratios the mobility of OppA tended to decrease weakly, as one would
expect, because the mean free path of diffusion decreases. However, the
observed heterogeneities in protein/lipid ratio of both OppA and OppBCDF
did not signiﬁcantly correlate with the diffusion constant (Spearman’s rho,
P ¼ 5%; Fig. S1).
The laser scanning confocal microscope is based on an inverted micro-
scope Axiovert S 100 TV (Zeiss, Jena, Germany) in combination with a gal-
vanometer optical scanner (model 6860, Cambridge Technology, Watertown,
MA) and a microscope objective nano-focusing device (P-721, PI). The two
laser beams (488 nm, argon ion laser, Spectra Physics and 633 nm, He-Ne
laser, JDS Uniphase) were focused by a Zeiss C-Apochromat inﬁnity-
corrected 1.2 NA 633 water immersion objective for excitation of the Alexa
Fluor 488 and 633 ﬂuorophores. The ﬂuorescence was collected through the
same objective, separated from the excitation beams by a beam-pick off plate
(BSP20-A1, ThorLabs) and split into two channels by a dichroic beam
splitter (585dcxr, Chroma Technology, Rockingham, VT), and ﬁnally di-
rected through emission ﬁlters (HQ 535/50 and HQ675/50, Chroma Tech-
nology) and pinholes (diameter of 30 mm) onto two avalanche photodiodes
(SPCM-AQR-14, EG&G). The ﬂuorescence signals were digitized and auto-
and cross-correlation curves were calculated using a multiple t algorithm.
The setup was calibrated by measuring the known diffusion coefﬁcients
of Alexa Fluor 488 and 633 in water (Invitrogen;D¼ 300mm2/s). The lateral
radii vxy, deﬁned as the point were the ﬂuorescence count rate dropped e
2
times, were 180 nm for Alexa ﬂuor 488 and 240 nm for Alexa ﬂuor 633.
Overlap of the two confocal volumes for dual-color FCCS experiments was
optimized by maximizing the cross-correlation signal of double-labeled
DNA, which was made by annealing equimolar amounts of 59-ATTATT-
GAGTGGTCACTTTAAA-39 labeled on the 59-end with Alexa Fluor 488
and 59 TTTAAAGTGACCACTCAATAAT-39 labeled on the 59-end with
Alexa Fluor 633 (IBA, St. Louis, MO). The overall efﬁciency of the ﬂuo-
rescence cross-correlation was found to be better than 80%. Crosstalk was
lower then 5%. Auto- and cross-correlation curves were ﬁtted with a one-
component three- (22) or two-dimensional diffusion model (23). Two-
component ﬁts were attempted in selected experiments; however, these did
not yield interpretable data because of the relatively small changes observed
in diffusion coefﬁcients and the large errors between the measurements.
Miscellaneous
Mutations were conﬁrmed by restriction analysis and DNA sequencing.
Protein concentrations of membrane vesicles were determined according to a
modiﬁed version (BioRad DC protein assay) of the method of Lowry et al.
(24), using bovine serum albumin as a standard. The concentrations of pu-
riﬁed OppA and OppBCDF were determined before reconstitution into
LUVs by measuring the absorption at 280 nm and using extinction coefﬁ-
cients of 1.605 and 0.990 (mg/mL)1cm1, respectively.
RESULTS
Lateral mobility of OppA is reduced in
OppBCDF-containing GUVs
Previous experiments showed that the lateral mobility of
lipid-anchored OppA in GUVs was comparable to that of
ﬂuorescent lipids (19), which is consistent with the Saffman-
Delbru¨ck model for Brownian motion in biological mem-
branes (25). Since the mobility of integral membrane proteins
was 2–3 times lower than that of OppA (19), we anticipated
that we could monitor the binding of OppA to its cognate
membrane complex by autocorrelation analysis. Binding of
ﬂuorescent-labeled OppA to OppBCDF would result in a
reduced mobility of the labeled protein. A single-cysteine
mutant of OppA, OppA (I602C), was labeled with Alexa
Fluor 488 and reconstituted at a 1:50 (w/w) protein/lipid ra-
tio, which corresponds to;3.5 nmol OppA/m2 of membrane
surface (13). OppBCDF was coreconstituted at a 1:20 (w/w)
protein/lipid ratio, resulting in approximately equal amounts
of OppA and OppBCDF complex molecules in the mem-
brane. At these concentrations, according to the estimated
KM of OppBCDF for liganded OppA (;1.75 nmol/m
2; 13),
most OppBCDF complexes are interacting with OppA pro-
vided the OppAs are in the peptide-bound state. In Table 1
the results of the autocorrelation measurements are presented.
In OppBCDF-containing GUVs, the mobility of OppA was
lowered compared with vesicles devoid of OppBCDF, which
could reﬂect binding or is because of increased membrane
crowding. The dissociation constant (KD) for binding of
bradykinin (peptide with the sequence RPPGFSPFR) to
OppA is 0.1 mM (18,26). On addition of 10 mM bradykinin,
that is, when all the OppA molecules are in the ligand-bound
state, OppA diffusion slowed down from 3.1 6 0.4 to 2.3 6
0.5 (3 108 cm2/s). In vanadate-trapped transition state
conditions, that is, in the presence of substrate, MgATP and
ortho-vanadate (Vi), OppA mobility was again as fast as
without peptide (3.2 6 0.3 3 108 cm2/s). In the absence of
peptide, however, no distinction could be made between
OppA binding to OppBCDF and reduced lipid mobility in
general as a consequence of the mere presence of OppBCDF
(increased crowding). A similar reduction in mobility com-
pared to ﬂuorescent-labeled OppA was observed for the
TABLE 1 Lateral mobility of OppA in OppBCDF-containing GUVs
Protein composition of GUVs Additions to rehydration buffer
OppA-AF488* OppBCDFy 10 mM bradykinin 3 mM MgATP plus 0.5 mM Vi Diffusion coefﬁcient (108 cm2/s)z
1    7.5 6 1.8
1 1   3.1 6 0.4
1 1 1  2.3 6 0.5
1 1 1 1 3.2 6 0.3
*OppA (I602C) labeled with Alexa Fluor 488 was reconstituted at a 1:50 (w/w) protein/lipid ratio.
yOppBCDF was reconstituted at a 1:20 (w/w) protein/lipid ratio.
zDiffusion coefﬁcients represent the average of at least two independent experiments of at least ﬁve measurements each, and the SD values are given. The
FCS setup was calibrated with free Alexa probes.
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ﬂuorescent lipid analog DiO (from 7.76 0.8 to 3.16 0.23
108 cm2/s), suggesting an effect of the increased membrane
crowding when reconstituting OppBCDF at protein/lipid
ratios of 1:20 (w/w). Taken together the data indicate that
liganded OppA binds speciﬁcally to OppBCDF, but the au-
tocorrelation measurements alone are not sufﬁcient to per-
form a detailed analysis of the OppA/OppBCDF interaction.
Fluorescence cross-correlation measurements
To monitor the binding of OppA to OppBCDF by FCCS, a
single-cysteine mutant of the OppC component of OppBCDF
was constructed. OppA (I602C) and OppBC(I296C)DF were
puriﬁed, labeled with Alexa Fluor 488 or Alexa Fluor 633
(Fig. 1), respectively, and functionally incorporated into
GUVs. As anticipated from previous results (19), all com-
binations of labeled SBPs and membrane complexes were
active in peptide binding as well as transport (Table 2).
Again, a relatively high concentration of OppA (1:50 (w/w)
protein/lipid ratio) was used because of the anticipated low
afﬁnity interaction of the SBP with its membrane complex
(13). The amount of coreconstituted OppBCDF was low-
ered to 1:100 (w/w), such that the ﬁnal concentrations of
the different proteins used in the FCCS experiments were
equivalent to those used previously in uptake assays with
proteo-LUVs and radioactive peptides (13). This experi-
mental setup also more closely resembles the in vivo situation
in which an excess of OppA over OppBCDF exists. The
maximal ﬂuorescence cross-correlation amplitude Gmaxcc that
can be obtained in this situation, assuming that Alexa Fluor
633-labeled OppBCDF binds Alexa Fluor 488-labeled OppA
in a 1:1 stoichiometry, is given by:
G
max
cc ¼ 2
v
2
488
v
2
4881v
2
633
G488; (1)
where G488 is the amplitude of the green channel, and v488
and v633 are the lateral radii of the 488 and 633 confocal
volumes, respectively. Note that this equation holds for a
two-dimensional system and is only valid when an excess of
Alexa Fluor 488-labeled OppA is present over Alexa Fluor
633-labeled OppBCDF. In the reverse situation, that is with
1:50 (w/w) Alexa Fluor 633-labeled OppA and 1:100 (w/w)
Alexa Fluor 488-labeled OppBCDF, the amplitude of the
autocorrelation curve from the 633 channel was nearly zero
because of the high amount of OppA, and a cross-correlation
signal could not be obtained (not shown).
OppBCDF distinguishes ligand-bound from
ligand-free OppA
Fig. 2A shows confocal scans of GUVs containing ﬂuorescent-
labeled OppA and OppBCDF. The observation volume was
positioned on top of a GUV using a z-scan (Fig. 2 B). Fig. 2C
shows representative autocorrelation curves measured on
GUVs containing Alexa Fluor 488-labeled OppA and Alexa
Fluor 633-labeled OppBCDF. In the absence of peptide no
cross-correlation signal was detected indicating that, on the
timescale of the experiment, OppA was not associated with
OppBCDF. On addition of 20 mM bradykinin (Fig. 2 D) the
cross-correlation signal was 48 6 15% with respect to the
maximal possible signal (the latter corresponding to ;0.72
times the amplitude of the 488 channel as calculated using
Eq. 1), suggesting that liganded OppA was bound to
OppBCDF. A slight decrease in the mobility of OppBCDF
was observed as well, which might have been because of
OppA binding. However, the change in OppBCDF mobility
was not statistically signiﬁcant (from 2.3 6 0.5 to 1.7 6
0.6 3 108 cm2/s). In conclusion, the cross-correlation mea-
surements indicate that the membrane complex OppBCDF
efﬁciently discriminates between OppA in its unliganded and
liganded form and binds only the latter.
Oligomeric state of lipid-anchored OppA and
OppA/OppBCDF binding stoichiometry
To investigate the oligomeric state of membrane-anchored
OppA and the OppA/OppBCDF binding stoichiometry,
Alexa Fluor 488- and Alexa Fluor 633-labeled OppAs were
mixed 1:1 and coreconstituted into GUVs at a 1:100 (w/w)
protein/lipid ratio (total OppA/lipid ratio of 1:50 (w/w)), in
the absence or presence of nonlabeled OppBCDF. If, for
example, OppA were a dimer, 488- and 633-labeled proteins
would form 488-labeled homodimers, 488/633-labeled het-
erodimers, and 633-labeled homodimers, in a 1:2:1 ratio,
respectively. The heterodimers should give rise to a cross-
correlation signal. Assuming all OppAs would be present as
dimers, Gmaxcc is given by:
Gmaxcc ¼
2
3
v
2
633
v
2
4881v
2
633
G633; (2)
FIGURE 1 Puriﬁcation and ﬂuorescent labeling of single-cysteine Opp
variants. Ni21- nitrilotriacetic acid puriﬁed OppA I602C was labeled with
Alexa Fluor 488 (lanes 1 and 5) or 633 (lanes 3 and 7). OppBC(I296C)DF
labeled with Alexa Fluor 488 (lanes 2 and 6), or 633 (lanes 4 and 8) is
also shown. The proteins were visualized with either Coomassie brilliant
blue staining (lanes 1–4), or by illumination using UV-light (lanes 5–8).
The latter allowed veriﬁcation of the attachment of the ﬂuorophores to the
proteins. The positions of the OppABCDF proteins are indicated as are the
masses of the molecular mass marker (M) proteins (kDa).
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where G633 is the amplitude of the red channel, and v488 and
v633 are again the respective radii of the 488 and 633
confocal volumes. Note that, as with Eq. 1, Eq. 2 describes
the situation for a two-dimensional system. Thus, if OppA
were dimeric, a cross-correlation signal would be observed
with maximal amplitude of ;0.24 times that of the 633
curve.
Fig. 3 A and Table 3 show that no cross-correlation signal
was obtainedwith proteo-GUVs containing ‘‘double’’-labeled
OppA. Addition of 20 mM peptide had no effect on the ﬂuo-
rescence cross-correlation, which indicates that the oligo-
meric state of both the unliganded and liganded forms of
membrane-bound OppA is monomeric. When OppBCDF
was present in the proteo-GUVs as well, no cross-correlation
signal was obtained both in the absence and presence of
20 mM bradykinin. Control experiments with double-labeled
DNA (Fig. 3 B) conﬁrmed that the cross-correlation efficiency
of the setup was better than 80%, as described previously
TABLE 2 Peptide binding and transport activity of ﬂuorescent-labeled Opp reconstituted into LUVs
SBP*
Membrane
complexy
Binding activity
(nmol [3H]-bradykinin/mg OppA)z
Transport activity
(pmol [3H]-bradykinin/mg OppBCDF*min)§
OppA – 14 6 0{ –k
OppA-488** – 14 6 1{ n.d.
OppA-633yy – n.d. n.d.
OppA OppBCDF n.d. 70 6 34
OppA-488 OppBCDF n.d. 74 6 26
OppA-633 OppBCDF n.d. 90 6 25
OppA-488 OppBCDF-633zz n.d. 60 6 4
OppA-633 OppBCDF-488§§ n.d. 90 6 8
n.d., not determined.
*OppA and labeled variants were reconstituted at a 1:50 (w/w) protein/lipid ratio.
yOppBCDF and labeled variants were reconstituted at a 1:100 (w/w) protein/lipid ratio.
zThe concentration of [3H]-bradykinin was 3 mM.
§The concentration of [3H]-bradykinin was 0.7 mM. Measurements were done in at least two independent experiments; mean 6 SD values are given.
{Taken from Doeven and colleagues (19).
kTaken from Doeven and colleagues (13).
**OppA (I602C) labeled with Alexa Fluor 488.
yyOppA (I602C) labeled with Alexa Fluor 633.
zzOppBC(I296C)DF labeled with Alexa Fluor 633.
§§OppBC(I296C)DF labeled with Alexa Fluor 488.
FIGURE 2 Confocal scans and FCCS measurements
on ﬂuorescent Opp-containing proteo-GUVs. (A) Two-
dimensional cross sections obtained by (x,y) confocal
imaging of proteo-GUVs containing Alexa Fluor 488-
labeled OppA I602C (OppA-AF488) and Alexa Fluor
633-labeled OppBC(I296C)DF (OppBCDF-AF633). Im-
ages from the 488 (A1) and 633 (A2) channels are shown.
The scale bars are 10 mm. (B) Typical z-scan used to
localize the proteo-GUV membranes. Signals in the 488
and 633 channels are shown (high and low intensity traces,
respectively). An excess of OppA-AF488 over OppBCDF-
AF633 was incorporated in the GUVs (see text for details).
(C) FCCS experiment in 20 mM K-Hepes, pH 8.0. The
observation volumes were focused on top of a proteo-GUV.
Autocorrelation signals from OppA-AF488 (D) and
OppBCDF-AF633 (s) are shown. No cross-correlation
signal (lower curve, h) was detected. (D) FCCS experi-
ment in 20 mM K-Hepes, pH 8.0, plus 20 mM peptide
(bradykinin). The presence of a cross-correlation signal
(lower curve, h) indicates that OppA-AF488 and
OppBCDF-AF633 were bound. Curves were ﬁt with a
one-component, two-dimensional diffusion model (solid
lines), and the residuals are shown below the graph.
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(27). Next, we also established the ability to measure a cross-
correlation signal for self-interacting particles embedded in
the membrane. For this measurement, we used a well-studied
dimeric membrane protein, LacS, and coreconstituted LacS-
AF488 and LacS-AF633 in a 1:1 ratio; for the labeling with
Alexa dyes, the LacS C320A/A635C double mutant was
used (19). Again, signiﬁcant cross-correlation signals were
detected (Fig. 3 C), indicative of the presence of LacS-
AF488/LacS-AF633 heterodimers. Taken collectively, the
data of this and the previous paragraph suggest that a single
OppA, in the liganded conformation, binds to OppBCDF.
ATP-binding Induces OppA release
from OppBCDF
To obtain more detailed information on the catalytic cycle of
the Opp system, FCCS experiments were performed under
various conditions of energy supply. Whereas in the presence
of 20 mM bradykinin liganded OppA bound to OppBCDF
(Fig. 2 D), inclusion of 3 mM ATP with 1 mM EDTA in
addition to 20 mM of peptide dissipated the cross-correlation
signal completely. The signal was only slightly reduced in the
presence of 0.1 mM of ATP plus EDTA (Table 4). In the
absence of Mg21, ABC transporters bind ATP but do not
hydrolyze the nucleotide (3,5,28). Addition of 3 mM of the
nonhydrolyzable ATP-analog MgAMP-PNP resulted in the
same effect. The cross-correlation signal was also diminished
in the presence ofMgATP plus ortho-vanadate, the vanadate-
trapped transition state condition. However, cross-correlation
was observed in the presence of 20mMbradykinin and 3 mM
of caged-ATP, indicating that the mere presence of a high
concentration of adenine nucleotide was not sufﬁcient for
dissipation of the FCCS signal (not shown). Taken together,
these results suggest that binding of ATP to the NBDs results
in a conformational change that releases OppA from the
translocator (OppBCDF) complex.
FIGURE 3 FCCS measurements on dual-labeled OppA and control samples. (A) Proteo- GUVs in which equimolar amounts of OppA-AF488 and OppA-
AF633 were co-reconstituted (both at 1:100 (w/w) protein/lipid ratio). (B) AF488/AF633 double-labeled DNA control sample. (C) Proteo-GUV sample in
which LacS-AF488 and LacS-AF633 were coreconstituted (both at 1:1000 (w/w) protein/lipid ratio). Autocorrelation signals from the 488 (D), 633 (s), and
cross-correlation (h) channels are shown. Curves in A and C were ﬁt with a one-component, two-dimensional diffusion model (solid lines), those in B were ﬁt
with a one-component, three-dimensional diffusion model. The residuals are shown in the lower panels.
TABLE 3 FCCS results with GUVs containing double-labeled OppA
Protein composition of GUVs Additions to rehydration buffer
OppA-AF488* OppA-AF633y OppBCDFz 20 mM bradykinin Cross-correlation signal (%)§
1 1   ,5
1 1  1 ,5
1 1 1  ,5
1 1 1 1 ,5
*OppA (I602C) labeled with Alexa Fluor 488 was reconstituted at a 1:100 (w/w) protein/lipid ratio.
yOppA (I602C) labeled with Alexa Fluor 633 was reconstituted at a 1:100 (w/w) protein/lipid ratio.
zOppBCDF was reconstituted at a 1:100 (w/w) protein/lipid ratio.
§Percentage of the maximal possible cross-correlation signal with the combination of ﬂuorescent labels used (Eq. 2). Results of at least two independent
experiments of ﬁve measurements each are shown. G(0) values ranged from 0.015 to 0.1 for AF633 and from 0.05 to 0.3 for AF488 and were maximally
;0.002 for the cross-correlation signals.
Receptor-Translocator Interactions in Oligopeptide ABC Transporter 3961
Biophysical Journal 94(10) 3956–3965
DISCUSSION
We have analyzed the mechanism of oligopeptide transport
by the ABC uptake system Opp by FCS and FCCS mea-
surements under conditions mimicking intermediate stages of
the translocation cycle. Importantly, these experiments were
carried out with the proteins in the membrane-embedded
state and under conditions at which the transporters were
fully functional. Previous studies on SBP/TMD interactions
mostly involved the use of detergent-solubilized proteins or
permeabilized proteoliposomes (5,6). The OppBCDF com-
plex was not very stable in detergent solution as concluded
from size exclusion and blue-native polyacrylamide gel
electrophoresis experiments (M. K. Doeven and B. Poolman,
unpublished results). Binding of MalE to MalFGK2 has been
studied in permeabilized proteo-LUVs (6). However, for
Opp, this would involve the use of OppA lacking its N-ter-
minal lipid-modiﬁcation, a more artiﬁcial situation compared
to membrane-anchored OppA. Proteo-GUVs proved to be a
very good alternative for studying receptor-translocator in-
teractions in the oligopeptide transporter in a deﬁned, close-
to-native model membrane system.
Using proteo-GUVs, we previously showed that lipid-
anchoredOppA diffuseswith the same speed as lipids whereas
integral membrane proteins, such as OppBCDF, have a two-
to threefold lower lateral mobility (19,20). Therefore, we
investigated the OppA/OppBCDF interaction by measuring
changes in diffusion speed. Binding of ﬂuorescent-labeled
OppA to nonlabeled OppBCDF should result in a shift of the
autocorrelation curve toward longer diffusion times. In
OppBCDF-containing GUVs the mobility of OppA was in-
deed slower, and, on addition of peptide, mobility was re-
duced even further (Table 1). However, in the absence of
peptide, no distinction could be made between speciﬁc
binding of OppA to OppBCDF and a reduced lateral mobility
because of the mere presence of membrane-embedded pro-
tein complex. Such hindered diffusion in a relatively crow-
ded membrane environment is not unlikely, since it is known
that the presence of integral membrane proteins negatively
effects lipid lateral mobility at the lipid/protein ratios used in
our experiments (29,30).
To circumvent this problem, we turned to dual-color
FCCS, a technique ﬁrst experimentally realized by Schwille
and colleagues (31). Although this remains a technically
demanding technique, which can easily give rise to artifacts
(e.g., crosstalk between the detector channels), experiments
with double-labeled ﬂuorescent DNA indicated that in our
setup we had a stable, high degree of overlap between the two
laser focal volumes (Fig. 3 B; (27)). The overall FCCS efﬁ-
ciency was as high as ;80%. Furthermore, with the Alexa
dye couple used in our experiments, the contribution of
crosstalk to the cross-correlation signal was negligible
(,5%). Single-cysteine mutants of OppA and OppBCDF,
the latter bearing the cysteine substitution in one of the
subunits of the integral membrane complex (OppC), were
used for labeling with Alexa Fluor 488 or 633 maleimide
(Fig. 1). In each case the position of the cysteine was chosen
in the C-terminal part of the protein just in front of the His6-
tag used for puriﬁcation, and, as expected, labeling had no
effect on peptide binding or on transport activity ((19); Table
2). The ﬂuorophore that is attached to OppA presumably
sticks out from the surface of the protein (based on crystal
structures of OppA homologs (32–35)), whereas the one that
is attached to OppC is located in a short stretch of amino acids
after the last helix that traverses the membrane back to the
cytoplasmic side (36).
SBPs of ABC importers have been crystallized in open-
unliganded, open-liganded, closed-liganded, and closed-
unliganded conformations (34,37–39). In the presence of
substrate, the equilibrium is thought to lie strongly toward the
closed-liganded state, and only SBPs in this conformation
would interact productively with the membrane components.
Experiments with the histidine and maltose permeases,
however, revealed that SBPs in their unliganded form(s)
might also have access to the membrane complex, thereby
impairing transport function (14–16). BtuF, the SBP of the
vitamin B12 transporter, was shown to bind to detergent-
solubilized BtuCD even in the absence of substrate (40), and
this SBP may not dissociate from the membrane complex at
all during the catalytic cycle (10,11). The dual-color FCCS
experiments presented in Fig. 2 C and D revealed that
OppBCDF distinguishes substrate-bound from substrate-free
OppA, which is in line with previous results where inhibition
of transport activity by high levels of unliganded SBP (as
observed for the histidine and maltose transporters) could not
be demonstrated for the Opp system (13). Next to the possi-
bility that OppBCDF discriminates liganded from unliganded
SBP, a second explanation would be that the equilibrium in
the absence of substrate lies more strongly toward the open
conformation for OppA compared with other SBPs such as
HisJ, MalE, and BtuF, the SBPs of the afore mentioned his-
tidine, maltose, and vitamin B12 transporters, respectively.
This explanation would mean that the inhibition of transport
TABLE 4 FCCS results with GUVs containing Alexa Fluor
488-labeled OppA and Alexa Fluor 633-labeled OppBCDF in
1:50 and 1:100 (w/w) protein/lipid ratios
Additions to rehydration buffer
20 mM
bradykinin
(Mg) nucleotides 6
EDTA or Vi
Cross-correlation
signal (%)*
  ,5
1  48 6 15y
1 0.1 mM ATP 1 1 mM EDTA 32 6 6y
1 3 mM ATP 1 1 mM EDTA ,5
1 3 mM Mg-AMP-PNP ,5
1 3 mM Mg-ATP 1 0.5 mM Vi ,5
*Percentage of the maximal possible cross-correlation signal with the
combination of ﬂuorescent labels used (Eq. 1). Averages and SD values of
at least two independent experiments of ﬁve measurements each are given.
yThese numbers reﬂect a signiﬁcant cross-correlation signal; the differences
between the numbers is not signiﬁcant.
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observed with the maltose and histidine transporters was
caused by blocking of the membrane complex by SBPs in the
closed-unliganded state. Of the various possibilities, we favor
the scenario that OppBCDF discriminates liganded from
unliganded SBP.
Although it is generally assumed that the oligomeric state
of SBPs is monomeric, several early reports on these types of
proteins suggest that they are dimeric (41–44). Moreover,
ABC transporters have been found that have either one or two
SBPs fused to the translocator, resulting in the presence of two
or four SBPs per functional complex (45). Interaction be-
tween SBPs stimulated transport activity of the osmoregula-
tory ABC transporter OpuA from L. lactis (46). Fig. 3 A and
Table 3 show that a cross-correlation signal was not detected
in proteo-GUVs with Alexa Fluor 488 and 633-labeled OppA
coreconstituted, which strongly suggests that lipid-anchored
OppA does not form higher oligomeric aggregates. Addition
of 20mMpeptide and/or inclusion ofOppBCDF in theOppA-
containing GUVs did not change the cross-correlation signals
(not shown). Furthermore, sedimentation velocity and equi-
librium centrifugation experiments also showed that OppA
(without lipid anchor) is monomeric over a wide range of
conditions tested (M. K. Doeven and B. Poolman, unpub-
lished results). These results indicate that monomeric OppA
binds peptide and that a single (liganded) OppA molecule
binds to OppBCDF and is sufﬁcient for transport.
In case of the maltose transporter (Fig. 4 A), it has been
shown that on ATP binding to the substrate-loaded MalE:
MalFGK2 complex MalE opens (step III; (5)). At this stage
maltose is thought to be donated to a site in the TMDs, MalF
andG, or released into the cytoplasm directly. ATPhydrolysis
is required to dissociate unligandedMalE fromMalFGK2 and
to complete the transport cycle (step IV; (6)). Our results with
the oligopeptide transporter (Fig. 4 B) show that ATP binding
is sufﬁcient to dissociate OppA from OppBCDF (step III).
The ATP-dependent release of OppA was observed under
conditions that preclude nucleotide hydrolysis (ATP without
Mg21 and excess of EDTA; use of the nonhydrolyzable an-
alog AMP-PNP) and conditions that stabilize the transition
state (Mg-ATP with ortho-vanadate). Ortho-vanadate has
been previously shown to be an effective inhibitor of Opp-
mediated transport (47) presumably by trapping the transition
state (6,28). These observations suggest that on binding of
ATP the peptide may have already been donated to a binding
site in the membrane. ATP-hydrolysis and subsequent release
of ADP and Pi would then reorient this site to complete the
catalytic cycle (step IV). The fact that OppA dissociates as
soon as ATP is bound whereas MalE merely opens but is not
released (e.g., in the presence of ortho-vanadate) might be ex-
plained by the above discussed observations that OppBCDF
distinguishes liganded from unliganded SBP more efﬁciently
(13,15).
Although the proposed mechanisms of SBP-dependent
uptake systems thus appear somewhat variable in respect to
the timing of SBP/TMD interactions during the catalytic cy-
cle, a comparison with the proposed mechanism for ABC
FIGURE 4 Mechanistic models for maltose (Mal)
and oligopeptide (Opp) uptake and comparison to an
ABC efﬂux system. Transport substrate and Mg-ATP
are indicated by solid circles and ovals, respec-
tively. Hydrolyzed ATP is depicted as split ovals.
For simplicity, it is assumed that each system binds
and hydrolyzes two molecules of ATP per translo-
cation cycle. Further explanation is provided in the
Discussion.
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efﬂux systems (Fig. 4 C; (3,4)) reveals important conserved
features (48). The largest difference is in the way substrate is
bound (Fig. 4, steps I and II). ABC uptake systems require
SBPs to signal the availability of substrate on the outside,
whereas in ABC exporters the TMD binding site is readily
accessible from the cytoplasmic face of the membrane. For
bothABC importers and exporters, ATP-binding is thought to
result in an altered accessibility of this TMD binding site in
respect to the face of the membrane (step III; (3,4)). In ABC
uptake systems this means that substrate now can enter the
channel, whereas in the case of ABC export, substrate is re-
leased into the external medium. A second common feature is
that on ATP-hydrolysis the transporter is thought to return to
its initial conformation, thereby completing the catalytic cycle
(step IV).
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